Nature Biomedical Engineering, Published online: 23 June 2026; doi:10.1038/s41551-026-01723-6 A self-amplifying RNA circuit whose replication is activated by an FDA-approved small molecule enables precise, reversible and programmable control of RNA amplification and antigen expression for improved therapeutic and vaccine design.